Skip to content
10-Q

Quarterly Report

EIDOS THERAPEUTICS, INC.

0001564590-20-048909

← back to feed
Filed
Oct 29, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Oct 27, 2020 38.66M sh
Shares Diluted Q3 2020 · Sep 30, 2020 38.39M sh
Shares Diluted Q3 2020 · Sep 30, 2020 38.23M sh
Shares Diluted Q3 2020 · Sep 30, 2019 37.71M sh
Shares Diluted Q3 2020 · Sep 30, 2019 36.36M sh
Capex Q3 2020 · Sep 30, 2020 $350K
Capex Q3 2020 · Sep 30, 2019 $147K
Operating Cash Flow Q3 2020 · Sep 30, 2020 −$68.57M
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$15.14M
Long Term Debt Q3 2020 · Sep 30, 2020 $16.73M
Long Term Debt Q3 2020 · Dec 31, 2019 $16.11M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $147.33M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $191.16M
Cash And Equivalents Q3 2020 · Sep 30, 2019 $165.82M
Cash And Equivalents Q3 2020 · Dec 31, 2018 $157.15M
Stockholders Equity Q3 2020 · Sep 30, 2020 $122.86M
Stockholders Equity Q3 2020 · Jun 30, 2020 $149.31M
Stockholders Equity Q3 2020 · Mar 31, 2020 $174.85M
Stockholders Equity Q3 2020 · Dec 31, 2019 $171.43M
Stockholders Equity Q3 2020 · Sep 30, 2019 $163.95M
Stockholders Equity Q3 2020 · Jun 30, 2019 $131.85M
Stockholders Equity Q3 2020 · Mar 31, 2019 $144.3M
Stockholders Equity Q3 2020 · Dec 31, 2018 $155.01M
Current Liabilities Q3 2020 · Sep 30, 2020 $13.83M
Current Liabilities Q3 2020 · Dec 31, 2019 $10.43M
Total Liabilities Q3 2020 · Sep 30, 2020 $38.5M
Total Liabilities Q3 2020 · Dec 31, 2019 $32.39M
Current Assets Q3 2020 · Sep 30, 2020 $153.55M
Current Assets Q3 2020 · Dec 31, 2019 $195.92M
Total Assets Q3 2020 · Sep 30, 2020 $161.35M
Total Assets Q3 2020 · Dec 31, 2019 $203.82M
Eps Diluted Q3 2020 · Sep 30, 2020 −$0.79
Eps Diluted Q3 2020 · Sep 30, 2020 −$2.14
Eps Diluted Q3 2020 · Sep 30, 2019 $0.18
Eps Diluted Q3 2020 · Sep 30, 2019 −$0.52
Eps Basic Q3 2020 · Sep 30, 2020 −$0.79
Eps Basic Q3 2020 · Sep 30, 2020 −$2.14
Eps Basic Q3 2020 · Sep 30, 2019 $0.19
Eps Basic Q3 2020 · Sep 30, 2019 −$0.52
Sga Expense Q3 2020 · Sep 30, 2020 $6.96M
Sga Expense Q3 2020 · Sep 30, 2020 $22.59M
Sga Expense Q3 2020 · Sep 30, 2019 $5.95M
Sga Expense Q3 2020 · Sep 30, 2019 $12.29M
Rd Expense Q3 2020 · Sep 30, 2020 $22.57M
Rd Expense Q3 2020 · Sep 30, 2020 $58.07M
Rd Expense Q3 2020 · Sep 30, 2019 $11.99M
Rd Expense Q3 2020 · Sep 30, 2019 $33.03M
Net Income Q3 2020 · Sep 30, 2020 −$30.18M
Net Income Q3 2020 · Sep 30, 2020 −$81.85M
Net Income Q3 2020 · Jun 30, 2020 −$28.85M
Net Income Q3 2020 · Mar 31, 2020 −$22.82M
Net Income Q3 2020 · Sep 30, 2019 $6.93M
Net Income Q3 2020 · Sep 30, 2019 −$18.86M
Net Income Q3 2020 · Jun 30, 2019 −$14.05M
Net Income Q3 2020 · Mar 31, 2019 −$11.73M
Operating Income Q3 2020 · Sep 30, 2020 −$29.4M
Operating Income Q3 2020 · Sep 30, 2020 −$80.53M
Operating Income Q3 2020 · Sep 30, 2019 $6.25M
Operating Income Q3 2020 · Sep 30, 2019 −$21.13M
Revenue Q3 2020 · Sep 30, 2020 $127K
Revenue Q3 2020 · Sep 30, 2020 $127K
Revenue Q3 2020 · Sep 30, 2019 $26.69M
Revenue Q3 2020 · Sep 30, 2019 $26.69M
Cost Of Revenue Q3 2020 · Sep 30, 2019 $2.5M
Cost Of Revenue Q3 2020 · Sep 30, 2019 $2.5M